Avantor appoints John Carethers, M.D. as independent Class III director

Avantor, Inc.

John Carethers, M.D., age 57, appointed to serve as Class III director with term expiring at 2022 annual meeting.
Carethers is Chair, Department of Internal Medicine at University of Michigan Medical School; member of National Academy of Medicine.
Standard non-employee director compensation: prorated $75,000 annual cash retainer and prorated $200,000 RSU grant.
RSUs vest one year from grant date, subject to continued service; board has determined independence under NYSE standards.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

John Carethers, M.D.

Director

AVTR · Avantor, Inc.

Effective: 2021-07-15
Filed: July 19, 2021, 7:59 PM ET

On July 15, 2021, the Board, upon the recommendation of its Nominating and Governance Committee, appointed John Carethers, M.D. as a Class III director with an initial term expiring at the Company’s 2022 Annual Meeting of Stockholders.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

John Carethers, M.D. was appointed as Director at Avantor, Inc..

Action: appointed
Role: Director

Exact text from the filing

On July 15, 2021, the Board, upon the recommendation of its Nominating and Governance Committee, appointed John Carethers, M.D. as a Class III director with an initial term expiring at the Company’s 2022 Annual Meeting of Stockholders.

View on SEC.gov

Avantor, Inc. filing history →

Source: SEC EDGAR

accession 0001722482-21-000194

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.